UNSPSC 51373339: Meperidine/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373339 Meperidine/promethazine, a Commodity code, shows limited recent state and local procurement activity tied directly to this specific pharmaceutical formulation. The recent opportunities posted under this code involve broader pharmaceutical procurement — naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and OTC products — rather than meperidine/promethazine compounds specifically. State and local issuing bodies purchasing under this code span county health departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions. The work involves securing pharmaceutical supply through competitive bidding, RFI market-intelligence gathering, and RFP-based multi-vendor contracting for distribution through authorized wholesalers.

Recent activity includes Seminole County, Florida's IFB (IFB60459723LAS), posted June 30, 2026, with a July 26, 2023 response deadline, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas Health and Human Services Commission's RFI (HHS0017013) posted April 3, 2026 to explore direct-to-manufacturer prescription program models; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802), posted January 20, 2026 with a March 26, 2026 proposal deadline, for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson. The geographic spread includes Florida, Texas, Minnesota, and Oregon through MMCAP membership. The code shows modest recent volume, with opportunities concentrated in state health agencies, county health departments, and multi-state cooperative purchasing vehicles rather than sustained single-commodity procurement of meperidine/promethazine specifically.